Cargando...
Atorvastatin solid dispersion for bioavailability enhancement
Atorvastatin calcium is a lipid-lowering agent. It has approximately 15% of bioavailability, remaining amount of drug showed adverse effect which is undesirable for patients. The objective of the study was to enhance the solubility and a dissolution profile of the atorvastatin (AT) calcium. Solid di...
Gardado en:
| Publicado en: | J Adv Pharm Technol Res |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4759982/ https://ncbi.nlm.nih.gov/pubmed/26955607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2231-4040.169873 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|